Generic drug debate

Norgine’s reply to ABPI

BMJ 2010; 340 doi: 10.1136/bmj.c1869 (Published 1 April 2010)
Cite this as: BMJ 2010;340:c1869

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter Martin, chief operating officer1
  1. 1Norgine, Norgine House, Harefield UB9 6NS
  1. pmartin{at}norgine.com

    Automatic generic substitution was originally proposed to the Department of Health by the Association of the British Pharmaceutical Industry (ABPI), so for the association not to profess support would be surprising.1 However, that the ABPI continues to present itself as the voice of the research based pharmaceutical industry in the UK is disappointing. …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL